Glycolytic Reprogramming in Lung Adenocarcinoma:
Molecular Mechanisms, Metabolic Biomarkers and Targeted Therapeutic Strategies

Lung adenocarcinoma (LUAD) is the most common and highly aggressive subtype of non-small cell lung cancer, characterized by metabolic reprogramming with enhanced glycolysis. Upregulation of key glycolytic enzymes [hexokinase 2 (HK2), pyruvate kinase M2 (PKM2), lactate dehydrogenase A (LDHA)] and lac...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Caini ZHANG, Yu FU, Huiqin FENG, Yuqing PAN, Ya LI, Chenglu HE
Fformat:	Artigo
Iaith:	Chinês
Cyhoeddwyd:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2026-04-01
Cyfres:	Chinese Journal of Lung Cancer
Pynciau:	lung neoplasms glycolysis lactylation metabolic biomarker metabolic reprogramming tumor microenvironment precision medicine
Mynediad Ar-lein:	http://dx.doi.org/10.3779/j.issn.1009-3419.2026.102.07
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!